4-(4-Methylbenzyl)thiomorpholine 1,1-dioxide

Catalog No. :
ACPUGB820
CAS No. :
477858-35-8
Molecular Formula :
C12H17NO2S
Molecular Weight :
239.34

IUPAC Name:4-(4-methylbenzyl)thiomorpholine 1,1-dioxide

4-(4-Methylbenzyl)thiomorpholine 1,1-dioxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$79.00Login to see priceIn stockInquiry
1g95%$296.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-Methylbenzyl)thiomorpholine 1,1-dioxide
IUPAC Name4-(4-methylbenzyl)thiomorpholine 1,1-dioxide
MDL No.MFCD02082680
Molecular FormulaC12H17NO2S
Molecular Weight239.34
SMILESO=S1(CCN(CC1)CC2=CC=C(C=C2)C)=O
InChI KeyPBEMXBVPRZGFNM-UHFFFAOYSA-N
Synonym4-(4-METHYLBENZYL)-1LAMBDA6,4-THIAZINANE-1,1-DIONE;4-[(4-methylphenyl)methyl]-1lambda6-thiomorpholine-1,1-dione;4-[(4-methylphenyl)methyl]-1,4-thiazinane 1,1-dioxide;Thiomorpholine, 4-[(4-methylphenyl)methyl]-, 1,1-dioxide;4-(4-Methylbenzyl)thiomorpholine 1,1-dioxide
CAS No.477858-35-8
PubChem CID2815708

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H319
Precautionary Statement(s)
P264-P280-P305+P351+P338-P337+P313

Synthetic Route by SureRoute

1. ACPUGB820 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOBAP825 route compound structure diagram
    ACOBAP82539093-93-1 In Stock
  4. Then
  5. ACPUGB820 route product structure diagram
    ACPUGB820477858-35-8 In Stock
Inquiry

2. ACPUGB820 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKOVF910 route compound structure diagram
    ACKOVF910104-87-0 In Stock
  2. Plus
  3. ACOBAP825 route compound structure diagram
    ACOBAP82539093-93-1 In Stock
  4. Then
  5. ACPUGB820 route product structure diagram
    ACPUGB820477858-35-8 In Stock
Inquiry

Comments (0)